Lisa Gabler

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Bernhard Englinger, Sebastian Kallus, Julia Senkiv et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 61 citations · Full text

Medicine, Oncology, Pharmacology +14

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup

Christine Pirker, Ágnes Bilecz, Michael Grusch et al. · Clinical Cancer Research · 2020 · 45 citations

Medicine, Cancer Biology, Oncology +15

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma

Lisa Gabler, Daniela Lötsch, Dominik Kirchhofer et al. · Acta Neuropathologica Communications · 2019 · 43 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues

Ana‐Iris Schiefer, Laura Parlow, Lisa Gabler et al. · Journal of Molecular Diagnostics · 2016 · 33 citations

Medicine, Pathology, Histology +12

Targeting fibroblast growth factor receptors to combat aggressive ependymoma

Daniela Lötsch, Dominik Kirchhofer, Bernhard Englinger et al. · Acta Neuropathologica · 2021 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +16